Cardiac-specific TGR5−/− mice exhibit more severe cardiac dysfunction and myocardial hypertrophy, while TGR5 activation can prevent lipotoxicity and cardiac dysfunction, inhibiting cardiac hypertrophy (Fleishman and Kumar, 2024; Wang et al., 2024). Here, GPBAR1 is linked to cardiac hypertrophy.